Mapping endocrine toxicity spectrum of immune checkpoint inhibitors: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase

Samankaltaisia teoksia

• Gastrointestinal toxicities associated with immune checkpoint inhibitors: a disproportionality analysis leveraging VigiBase, the WHO Adverse Drug Reaction Database
  Tekijä: HUANG, Sifu, et al.
  Julkaistu: (2021)
• Adverse Event Reporting with Immune Checkpoint Inhibitors in Older Patients: Age Subgroup Disproportionality Analysis in VigiBase
  Tekijä: Noseda, Roberta, et al.
  Julkaistu: (2021)
• Pleural adverse drugs reactions and protein kinase inhibitors: Identification of suspicious targets by disproportionality analysis from VigiBase
  Tekijä: Mahé, Julien, et al.
  Julkaistu: (2018)
• Cardiovascular Safety of COVID-19 Treatments: A Disproportionality Analysis of Adverse Event Reports from the WHO VigiBase
  Tekijä: Hoi K. Cheng, et al.
  Julkaistu: (2025-09-01)
• Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBase
  Tekijä: Sandberg, Lovisa, et al.
  Julkaistu: (2020)